These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7940809)

  • 21. Angiotensin-converting enzyme inhibitor-induced anemia and treatment for erythrocytosis in renal transplant recipients.
    Satoh S; Kaneko T; Seino K; Abe T; Omori S; Sugimura J; Fujioka T; Kubo T
    Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):343-7. PubMed ID: 7666600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction of posttransplant erythrocytosis with enalapril.
    Rell K; Koziak K; Jarzyo I; Lao M; Gaciong Z
    Transplantation; 1994 Apr; 57(7):1059-63. PubMed ID: 8165703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ramipril in post-renal transplant erythrocytosis.
    Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
    J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
    Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A
    Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
    Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
    Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Jun; 54(2):145-8. PubMed ID: 12070465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of post-renal transplant erythrocytosis with enalapril.
    Rostaing L; Boisseau M; Durand D; Huyn A; Lloveras JJ; Suc JM
    Transplant Proc; 1993 Jun; 25(3):2325-6. PubMed ID: 8516915
    [No Abstract]   [Full Text] [Related]  

  • 29. Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists.
    Singh V; Sud K; Mittal BR; Kohli HS; Gupta KL; Sakhuja V
    Transplant Proc; 2002 Dec; 34(8):3191-2. PubMed ID: 12493416
    [No Abstract]   [Full Text] [Related]  

  • 30. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine.
    Opelz G
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1289-90. PubMed ID: 8442115
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
    Ahmed S; Ahmed E; Naqvi R; Qureshi S
    J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
    Trivedi H; Lal SM
    Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumors after renal transplantation.
    Büyükpamukçu N; Karakayali H; Bilgin N
    Transplant Proc; 1996 Aug; 28(4):2317-8. PubMed ID: 8769235
    [No Abstract]   [Full Text] [Related]  

  • 34. CyA monotherapy in patients over 50 years of age after renal transplantation: short-term results.
    Morales JM; Sancho S; Muñoz Cepeda MA; Andres A; Campo C; Alcazar JM; Rodicio JL
    Transplant Proc; 1992 Feb; 24(1):37-8. PubMed ID: 1539322
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of aminophylline and enalapril in posttransplant polycythemia.
    Mazzali M; Filho GA
    Transplantation; 1998 Jun; 65(11):1461-4. PubMed ID: 9645803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
    MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
    Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study.
    Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A
    Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889
    [No Abstract]   [Full Text] [Related]  

  • 39. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 40. Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients.
    Lal SM; Trivedi HS; Ross G
    Int J Artif Organs; 1995 Jan; 18(1):13-6. PubMed ID: 7607751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.